Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial

NCT: NCT07746154 · NOT_YET_RECRUITING

NCT IDNCT07746154
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-02-01
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

This pilot study is testing a short brain training program called neurofeedback in adults with alcohol use disorder. Participants will complete three sessions over about one week. The goal is to learn if this approach is easy to complete, well tolerated, and acceptable to participants. We will also explore whether it is associated with changes in alcohol cravings and drinking.

Frequently Asked Questions

What is Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial?

Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial is a clinical trial registered under NCT07746154. Current status: NOT_YET_RECRUITING.

What is the status of NCT07746154?

The current status of NCT07746154 (Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial) is: NOT_YET_RECRUITING.

When did Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial start?

Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑